SCHEMBL11633588

SCHEMBL11633588

CC(C)(C)NCC(O)COc1cc(C2=NNC(=O)CC2)ccc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.60
ADRB2 P07550 10/20 0.46
ADRB1 P08588 8/20 0.46
HTR1A P08908 2/20 0.46
OPRK1 P41145 1/20 0.46
PDE4B Q07343 2/20 0.43
PDE4A P27815 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
ADRB3 P13945 5/20 0.41
TSHR P16473 1/20 0.41
SLC6A4 P31645 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
ALOX15 P16050 1/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11704925 0.93 L3MBTL1 (0.52) L3MBTL1ADRB2ADRB1HTR1AOPRK1
SCHEMBL11634308 0.86 ACHE (0.53) L3MBTL1ADRB2ADRB1HTR1AOPRK1
SCHEMBL11703709 0.85 ADRB2 (0.49) ADRB2ADRB1HTR1AOPRK1PDE4B
SCHEMBL11700085 0.85 PDE4B (0.60) ADRB2ADRB1HTR1AOPRK1PDE4B
SCHEMBL11634268 0.85 ADRB2 (0.49) ADRB2ADRB1HTR1AOPRK1PDE4B
SCHEMBL9462545 0.84 L3MBTL1 (0.46) L3MBTL1ADRB2ADRB1HTR1AOPRK1
SCHEMBL11704716 0.84 ADRB2 (0.50) L3MBTL1ADRB2ADRB1HTR1AOPRK1
SCHEMBL11705278 0.83 L3MBTL1 (0.57) L3MBTL1ADRB2ADRB1HTR1AOPRK1
SCHEMBL11706953 0.83 ADRB2 (0.49) ADRB2ADRB1HTR1AOPRK1PDE4B
Hydrochloric Acid SCHEMBL11706892 0.83 ADRB2 (0.49) L3MBTL1ADRB2ADRB1HTR1AOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4082843-A 3-(3-(3-Substituted amino-2-hydroxypropoxy)phenyl)-6-hydrazino pyridazines and their use as vasodilators and β-adrenergic blocking agents SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1978-04-04 US disclosed